Jose Maria Eiros-Bouza

Prof. Dr. Jose Maria Eiros-Bouza

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
PMPatricia Munoz
Patricia Munoz
EBEmilio Bouza
Emilio Bouza
MCManuel Cuenca-Estrella
Manuel Cuenca-Estrella
JEJose Maria Eiros-Bouza
Jose Maria Eiros-Bouza
MPMaria Jesús Pérez
Maria Jesús Pérez
TPTeresa Peláez
Teresa Peláez
Background. Saccharomyces cerevisiae is well known in the baking and brewing industry and is also used as a probiotic in humans. However, it is a very

11 December 2009 in Critical Care
Verified
Journal Article
Open access
PDF file
JBJesús F. Bermejo-Martin
Jesús F. Bermejo-Martin
RLRaul Ortiz de Lejarazu
Raul Ortiz de Lejarazu
TPTomàs Pumarola
Tomàs Pumarola
JRJordi Rello
Jordi Rello
RARaquel Almansa
Raquel Almansa
DKDavid J Kelvin
David J Kelvin
Introduction: Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild and severe patients infected with nvH1N1. Methods: We profiled 29 cytokines and chemokines and evaluated the haemagglutination inhibition activity as quantitative and qualitative measurements of host immune responses in serum obtained during the first five days after symptoms onset, in two cohorts of nvH1N1 infected patients. Severe patients required hospitalization (n = 20), due to respiratory insufficiency (10 of them were admitted to the intensive care unit), while mild patients had exclusively flu-like symptoms (n = 15). A group of healthy donors was included as control (n = 15). Differences in levels of mediators between groups were assessed by using the non parametric U-Mann Whitney test. Association between variables was determined by calculating the Spearman correlation coefficient. Viral load was performed in serum by using real-time PCR targeting the neuraminidase gene. Results: Increased levels of innate-immunity mediators (IP-10, MCP-1, MIP-1β), and the absence of anti-nvH1N1 antibodies, characterized the early response to nvH1N1 infection in both hospitalized and mild patients. High systemic levels of type-II interferon (IFN-γ) and also of a group of mediators involved in the development of T-helper 17 (IL-8, IL-9, IL-17, IL-6) and T-helper 1 (TNF-α, IL-15, IL-12p70) responses were exclusively found in hospitalized patients. IL-15, IL-12p70, IL-6 constituted a hallmark of critical illness in our study. A significant inverse association was found between IL-6, IL-8 and PaO2 in critical patients. Conclusions: While infection with the nvH1N1 induces a typical innate response in both mild and severe patients, severe disease with respiratory involvement is characterized by early secretion of Th17 and Th1 cytokines usually associated with cell mediated immunity but also commonly linked to the pathogenesis of autoimmune/inflammatory diseases. The exact role of Th1 and Th17 mediators in the evolution of nvH1N1 mild and severe disease merits further investigation as to the detrimental or beneficial role these cytokines play in severe illness.

29 May 2014 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
FLFrancisco J. Luquero
Francisco J. Luquero
LGLise Grout
Lise Grout
ICIza Ciglenecki
Iza Ciglenecki
KSKeita Sakoba
Keita Sakoba
BTBala Traore
Bala Traore
RGRebecca F Grais
Rebecca F Grais
The use of vaccines to prevent and control cholera is currently under debate. Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization; however, its effectiveness under field conditions and the protection it confers in the first months after administration remain unknown. The main objective of this study was to estimate the short-term effectiveness of two doses of Shanchol used as a part of the integrated response to a cholera outbreak in Africa.

8 April 2019 in Bioinformatics
Verified
Journal Article
Closed access
NQNarciso Martín Quijada
Narciso Martín Quijada
DRDavid Rodríguez-Lázaro
David Rodríguez-Lázaro
JEJose Maria Eiros-Bouza
Jose Maria Eiros-Bouza
Marta HernandezMarta Hernandez
Marta Hernandez
Motivation: The progress of High Throughput Sequencing (HTS) technologies and the reduction in the sequencing costs are such that Whole Genome Sequencing (WGS) could replace many traditional laboratory assays and procedures. Exploiting the volume of data produced by HTS platforms requires substantial computing skills and this is the main bottleneck in the implementation of WGS as a routine laboratory technique. The way in which the vast amount of results are presented to researchers and clinicians with no specialist knowledge of genome sequencing is also a significant issue. Results: Here we present TORMES, a user-friendly pipeline for WGS analysis of bacteria from any origin generated by HTS on Illumina platforms. TORMES is designed for non-bioinformatician users, and automates the steps required for WGS analysis directly from the raw sequence data: sequence quality filtering, de novo assembly, draft genome ordering against a reference, genome annotation, multi-locus sequence typing (MLST), searching for antibiotic resistance and virulence genes, and pangenome comparisons. Once the analysis is finished, TORMES generates and interactive web-like report that can be opened in any web browser and shared and revised by researchers in a simple manner. TORMES can be run by using very simple commands and represent a quick an easy way to perform WGS analysis. Availability and implementation: TORMES is free available at https://github.com/nmquijada/tormes. Supplementary information: Supplementary data are available at Bioinformatics online.

12 December 2012 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
FOFernando De Ory
Fernando De Ory
AAAna Avellon
Ana Avellon
JEJuan E. Echevarría
Juan E. Echevarría
MSMaria Paz DE SALUD Sanchez-Seco
Maria Paz DE SALUD Sanchez-Seco
GTG. Trallero
G. Trallero
MMMaría Sonia Vázquez Morón
María Sonia Vázquez Morón

1 May 2015 in Journal of Infection
Verified
Journal Article
Closed access
RARaquel Almansa
Raquel Almansa
MHMaría Heredia-Rodríguez
María Heredia-Rodríguez
EGEsther Gómez-Sánchez
Esther Gómez-Sánchez
DADavid Andaluz-Ojeda
David Andaluz-Ojeda
VIVerónica Iglesias
Verónica Iglesias
ETEduardo Tamayo
Eduardo Tamayo